FDA Inspection 1194222 — New York Blood Center, Inc.
The FDA completed an inspection of New York Blood Center, Inc. on Dec 19, 2022 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 19, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- New Brunswick, NJ (United States)